X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

Yuvraj_pawp by Yuvraj_pawp
31st March 2015
in Research & Development

Micromeritics’ Instrument Grant Committee has recently selected its latest grant recipient.

A 3Flex Surface Characterisation Analyser was awarded to the Civil and Environmental Engineering Department of MIT.

MIT senior research scientist Dr Roland Pellenq said: “The department aims at determining the poro-mechanical and transport properties of the most important technological, economical and environmental materials in the world: cement and concrete, source rocks for oil and gas, oxide, glasses and clays for nuclear energy and nuclear waste storage.”

The company will use a ‘nanoscope’ method to scrutinise and manipulate materials in a broad range of magnifications.

Pore structure characterisation, including porosity assessment, pore size distribution, and specific surfaces are key factors in their approach and is the reason they applied for the Micromeritics gift award.

Dr Pellenq is one of the co-founders and lead scientist of the Concrete Sustainability Hub, CSH@MIT, an interdisciplinary research centre dedicated to the reduction of the environmental footprint of the cement and concrete industry.

The centre was opened in October 2009.

Dr Pellenq was hired as a MIT senior research scientist in November 2010 and is the director of the CNRS-MIT joint laboratory ‘Multiscale Material Science of Energy and Environment.’

Micromeritics president Preston Hendrix said: “This program is designed to promote and advance the acquisition and use of particle characterisation instrumentation in non-profit universities and institutions where other means of funding are not generally available.”

Mr Hendrix appointed a special Grant Selection Committee to ensure the success and effectiveness of the program.

Micromeritics’ Instrument Grant Program is intended to provide particle characterisation instruments to non-profit universities and research organisations to foster and support meritorious research projects.

A maximum of one instrument / integrated system will be awarded per calendar quarter.

Applications may be submitted anytime in accordance with the application instructions and will remain active for a period of one year from the date of submission.

Visit the Grant Program website for a detailed grant description, application requirements and application.

Previous Post

GSK to provide meningitis B vaccine in UK

Next Post

Novartis's Jadenu receives FDA approval to treat chronic iron overload

Related Posts

Tumors Can Get Destroyed By Bacteria-Aid To Immune System
News

Tumors Can Get Destroyed By Bacteria-Aid To Immune System

16th March 2023
News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Featured

Animal Testing Could See An End With An Artificial Model

28th February 2023
Featured

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

27th February 2023
Next Post

Novartis's Jadenu receives FDA approval to treat chronic iron overload

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In